myelofibrosis

Showing NaN - NaN of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

Recruiting
  • Myeloproliferative Disorders
  • +4 more
  • La Jolla, California
  • +184 more
Aug 22, 2022

Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +165 more
Aug 19, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)

Suspended
  • Myelofibrosis
  • Adelaide, South Australia, Australia
  • +37 more
Aug 18, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib)

Completed
  • Myelofibrosis
  • Winter Park, Florida
  • +17 more
Jan 10, 2022

Myelofibrosis Trial in Worldwide (PIM447, Ruxolitinib, LEE011)

Completed
  • Myelofibrosis
  • VIC, Melbourne, Australia
  • +8 more
Feb 7, 2022

Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)

Completed
  • Myelofibrosis
  • Imetelstat 4.7 mg/kg
  • Imetelstat 9.4 mg/kg
  • Birmingham, Alabama
  • +71 more
Aug 17, 2021

Myelofibrosis Trial in Worldwide (INC424, BKM120)

Terminated
  • Myelofibrosis
  • Herston, Queensland, Australia
  • +14 more
Dec 16, 2020

Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)

Completed
  • Polycythemia Vera
  • +2 more
  • JAK2V617F mutation
  • Olomouc, Czechia
  • +29 more
Dec 5, 2019

Myelofibrosis Trial in Worldwide (Ruxolitinib, Best Available Therapy (BAT))

Completed
  • Myelofibrosis
  • Innsbruck, Austria
  • +60 more
Jul 11, 2019

Patients With Myeloproliferative Disorders

Completed
  • Myeloproliferative Disease
  • +4 more
    • Scottsdale, Arizona
    • +21 more
    Dec 12, 2018

    Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia Trial in Worldwide (Deferasirox)

    Completed
    • Thalassemia
    • +3 more
    • Little Rock, Arkansas
    • +140 more
    Jun 3, 2011